Cognitive Function Clinical Trial
Official title:
16 Weeks' Dietary Supplementation With Iron and Iron + Vitamin C on Cerebral Blood Flow and Energy Expenditure in Women of Reproductive Age
Iron deficiency is the most prevalent nutritional deficiency worldwide with one in four estimated to be affected by iron deficiency anaemia. Women of reproductive age are at greatest risk for iron deficiency and anaemia due to iron losses during menstruation and childbirth as well as the increased need for iron throughout pregnancy. However, iron deficiency without anaemia is at least twice as common as iron deficiency anaemia with females aged 11-49 at the biggest risk of all. Despite this, it is commonly left undiagnosed. Those who are iron deficient non-anaemic can still suffer from the same common consequences of iron deficiency anaemia; these include unexplained fatigue, mood changes and decreased cognitive performance. It is postulated that for any cognitive and behavioural change to occur, a complementary change in neural functioning is required. A recent cross-sectional study has identified increases in cognitive demand to produce decrements in measures of cognitive performance and increases in brain activity and metabolic measures; the magnitude of such are evidenced to be directly related to iron status. However, such measures do not provide an estimate of overall oxygen consumption that is specific to the brain in order to be able to associate changes in cognitive performance and energy expenditure specifically to the brain itself. The current study aims to investigate the parallel effects of iron supplementation on cerebral haemodynamics and energy metabolism to determine the ability of iron to modulate whole body energy metabolism and utilisation of metabolic substrates at rest and during cognitive demand in a sample of non-anaemic iron deficient and iron sufficient women of reproductive age.
Each participant will be required to attend the laboratory on four occasions. The first is
comprised of a screening/training visit, which will take place in the afternoon for
approximately 2.5 hours. This will also be between days 21-28/ the week before onset of their
menstrual cycle. If they do not have menstrual bleeds then this appointment can be any
afternoon. This will comprise: briefing of requirements of the study; obtaining of informed
consent; confirmation of eligibility to take part, including collection of demographic data
and health screening, and training on the cognitive and mood measures. The training session
will follow standard operating procedures to decrease the chance of learning effects during
main trials. Extra training will be given where necessary.
Participants will be required to complete questionnaires based upon food frequency, caffeine
consumption and to estimate the number of hours of exercise completed on a weekly basis. A
menstrual cycle questionnaire will also be completed to estimate menstrual blood loss and so
that participants attend their testing visit during days 7-14 of their cycle. If participants
do not have a menstrual cycle due to contraceptive methods, then appointments will be
approximately two weeks apart. A finger-prick and venous blood sample will be collected from
participants, which will be analysed for iron status. Those whose haemoglobin levels are
<120g/L will be advised to seek advice from their GP. Participants who fell into the iron
status category of iron sufficient (haemoglobin ≥120 g/L and serum ferritin > 20 µg/L) or
non-anaemic iron deficient (haemoglobin ≥120 g/L and serum ferritin ≤ 20 µg/L) will be
informed of their eligibility for the intervention study by email or phone between the
initial visit and their next. This will include the option to enrol in an additional
assessment of neuroimaging and energy metabolism.
For the testing visit, participants will be asked to fast for 12 hours prior to the visit,
avoiding intake of all food and drink with the exception of water. They will also be asked to
avoid alcohol and refrain from intake of 'over the counter' medication for 24 hours.
Participants will arrive at the laboratory at a designated time in the morning. The following
procedures will take place prior to cognitive and mood testing:
Review of continued conformity to eligibility criteria Adverse event and concomitant
medication assessment Ensure that participant is in good health
Participants will then complete the baseline cognitive and mood assessments. Following this,
participants are informed of their iron status and will be briefed regarding the requirements
of the intervention study and additional assessment. Following this, informed consent will be
obtained prior to starting the additional assessment. Participants will have a frequency
domain near-infrared spectroscopy headband attached to the forehead to measure cerebral blood
flow at rest for five minutes. Following this, participants will instead have a continuous
wave near-infrared spectroscopy headband attached to the forehead to measure cerebral blood
flow, and a face mask fitted to measure expired air. Participants will have another five
minute rest before completing an additional battery of cognitive tasks for approximately
35-40 minutes. Once complete, participants will be randomised to one of three treatments and
be provided with a treatment diary to log treatment consumption and any adverse events
experienced.
Participants will return to the laboratory after 8 weeks to exchange treatment bottles and
diaries in order to check compliance.
Participants will finally return to the laboratory after a further 8 weeks (16 weeks total).
The same procedures will take place prior to cognitive and mood testing as completed at the
baseline testing visit, with the addition of finger prick and venous blood sample and weight
measurement. Participants will then complete the same cognitive, mood and neuroimaging and
energy metabolism assessments as completed during the baseline testing visit.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT03708692 -
Menstrual Cycle Phases on Recovery and Cognitive Function
|
||
Active, not recruiting |
NCT04505345 -
Virtual Reality Cognitive Training in Alcohol Use Disorder
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT02915913 -
Effects of Exercise Training on Cognitive Function and Neurotrophic Factors in Overweight Adults
|
N/A | |
Completed |
NCT01410097 -
Physical and Cognitive Function - Look AHEAD Ancillary Study
|
N/A | |
Completed |
NCT03826121 -
Efficacy and Safety of Sesame Oil Cake Extract on Improvement of Cognitive Function
|
N/A | |
Recruiting |
NCT05621278 -
Children to Adults Mental and Psychosomatic Health Study (CAMPS)
|
||
Completed |
NCT05498415 -
Feasibility, Acceptability, and Efficacy of the Sleep Move Stand Study
|
N/A | |
Completed |
NCT03208569 -
Anticholinergic Burden - Treatment Optimization
|
||
Completed |
NCT03793777 -
The Effect of Aronia Melanocarpa Extract on Cognitive Function
|
N/A | |
Recruiting |
NCT05525299 -
Reminiscence-Based Life Review on Copying With Existential Suffering Among Older Cancer Survivors
|
N/A | |
Completed |
NCT03698123 -
Performance Nutrition for Residents and Fellows
|
N/A | |
Completed |
NCT04543500 -
Self-regulation of Prefrontal Cortex During Emotional Cognitive Control
|
N/A | |
Recruiting |
NCT05891977 -
Effect of Tomato Paste Consumption on the Microbiota-gut-brain Axis in Healthy Adults
|
N/A | |
Recruiting |
NCT05591885 -
Nutrilite Memory Builder on the Improvement of Cognitive Function
|
N/A | |
Active, not recruiting |
NCT05575752 -
Acute Health Effects of High Temperature Exposure
|
N/A | |
Completed |
NCT03716609 -
Effects of Magnesium Supplementation on Hemodynamic Parameters and Cognitive Function
|
N/A | |
Completed |
NCT02763514 -
The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood
|
N/A | |
Completed |
NCT02675621 -
Investigation of Acute Mood and Cognitive Performance Effects of Beverages Containing Phenolics in Healthy Adults
|
N/A |